Enanta Pharmaceuticals reported $1.48M in Loan Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acorda Therapeutics ACOR:US $ 168.37M 2.2M
Amgen AMGN:US $ 31129M 1766M
Anika Therapeutics ANIK:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
AstraZeneca AZN:LN 17874M 120M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 44505M 3831M
Enanta Pharmaceuticals ENTA:US $ 1.48M 0M
GlaxoSmithKline GSK:LN 23047M 378M
Halozyme Therapeutics HALO:US $ 784.73M 784.73M
Insmed INSM:US $ 375.99M 4.96M
Intercept Pharmaceuticals ICPT:US $ 568.11M 7.53M
Karyopharm Therapeutics KPTI:US $ 241.79M 50.78M
Ligand Pharmaceuticals LGND:US $ 352.31M 89.98M
Neurocrine Biosciences NBIX:US $ 322M 4.1M
Novartis NOVN:VX SF 27399M 579M
Novavax NVAX:US $ 339.09M 23.03M
Ptc Therapeutics PTCT:US $ 1111.93M 120.99M
Sarepta Therapeutics SRPT:US $ 1091.11M 98.62M
Vertex Pharmaceuticals VRTX:US $ 572.86M 33.81M
Vital Therapies VTL:US $ 0M 0M